Clinical Trial Update: Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating neoadjuvant sintilimab combined with weekly metronomic chemotherapy for resectable locally advanced gastric cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Huashan Hospital | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING